Table 2.
Demographic Characteristics of the Study Population
Characteristic | Completed next appointment N=317 | Did not complete next appointment N=193 | p Valuea | All N=510 |
---|---|---|---|---|
Age in years | 38 | 40 | 0.26 | 39 |
Median (IQR) | (29–48) | (30–49) | (30–48) | |
Race | ||||
Number (%) | ||||
White | 139 (44%) | 51 (26%) | <0.001 | 190 (37%) |
Black | 148 (47%) | 134 (69%) | <0.001 | 282 (55%) |
Hispanic | 23 (7%) | 5 (3%) | 0.03 | 28 (5%) |
Other | 7 (2%) | 3 (2%) | 0.75 | 10 (2%) |
Male sex | 245 | 132 | 0.03 | 377 |
Number (%) | (77%) | (68%) | (74%) | |
MTF transgender | 4 | 2 | 1.00 | 6 |
Number (%) | (1%) | (1%) | (1%) | |
HIV risk factor | ||||
Number (%) | ||||
MSM | 182 (57%) | 87 (45%) | 0.008 | 269 (53%) |
Heterosexual contact | 113 (36%) | 79 (41%) | 0.26 | 192 (38%) |
IDU | 15 (5%) | 19 (10%) | 0.03 | 34 (7%) |
Other/unknown | 7 (2%) | 8 (4%) | 0.28 | 15 (3%) |
Year of entry into | 2012 | 2009 | <0.001 | 2011 |
care at the VCCC | (2006–2013) | (2002–2013) | (2005–2013) | |
Most recent CD4+ | 355 | 291 | 0.12 | 327 |
count (cells/mm3) | (152–583) | (129–489) | (142–560) | |
Most recent HIV-1 | 21,192 | 25,426 | 0.94 | 21,818 |
VL (copies/mL) | (2303–67,079) | (1311–72,252) | (2030–69,597) |
For comparison between those who completed and did not complete their next HIV healthcare provider appointment.
HIV, human immunodeficiency virus infection; IDU, injection drug use; IQR, interquartile range; MTF, male-to-female; MSM, male-to-male sexual contact; VCCC, Vanderbilt Comprehensive Care Clinic; VL, viral load.